What Lab Tests are Done with Breast Tissue?

Laboratory tests performed on breast tissue play an important role in diagnosing breast cancer and understanding the biological characteristics of a breast tumor. When a suspicious lump or abnormality is identified through mammography, ultrasound, MRI, or clinical examination, a biopsy may be performed to obtain a small sample of breast tissue.

The collected tissue is examined by a pathologist using microscopic, immunohistochemical, and, when required, molecular laboratory tests. These investigations help determine whether abnormal cells are cancerous, identify the type and grade of breast cancer, and provide important information for selecting an appropriate treatment approach.

Depending on the clinical situation, breast tissue may be evaluated for:

• Presence or absence of cancer cells
• Type of breast cancer
• Tumor grade
• Estrogen receptor (ER) status
• Progesterone receptor (PR) status
• HER2 status
• Ki-67 proliferation index
• Lymphovascular invasion
• Lymph node involvement
• Specific molecular or genetic alterations

Accurate laboratory analysis of breast tissue helps doctors combine pathology findings with imaging and clinical information to create a more individualized treatment plan.

Why are Laboratory Tests on Breast Tissue Important?

A breast biopsy provides more than simply an answer to whether cancer is present. Laboratory examination can reveal the characteristics of the tumor and its potential behavior.

Breast tissue testing can help doctors:

• Confirm or exclude breast cancer
• Identify the specific type of tumor
• Determine how abnormal the cancer cells appear
• Establish tumor grade
• Identify hormone receptor status
• Determine HER2 status
• Estimate how quickly tumor cells are multiplying
• Support treatment selection
• Provide information about prognosis

These findings can influence decisions regarding surgery, chemotherapy, hormonal therapy, HER2-targeted treatment, immunotherapy, or other systemic treatments.

What Happens to Breast Tissue After a Biopsy?

Once a biopsy is performed, the tissue sample is sent to a pathology laboratory for examination.

The laboratory process generally involves:

1. Specimen collection – Breast tissue is obtained through an appropriate biopsy technique.
2. Preservation – The tissue is placed in a suitable preservative to maintain its cellular structure.
3. Processing – The specimen is processed and embedded in paraffin wax.
4. Sectioning – Very thin tissue sections are prepared.
5. Staining – Routine stains are applied so that cells and tissue structures can be examined.
6. Microscopic examination – A pathologist evaluates the tissue under a microscope.
7. Additional testing – Immunohistochemistry or molecular testing may be performed when clinically required.
8. Pathology reporting – The findings are compiled into a report that supports diagnosis and treatment planning.

What is Histopathology of Breast Tissue?

Histopathology is one of the fundamental laboratory examinations performed on a breast biopsy or surgical specimen.

During histopathological examination, the pathologist evaluates the appearance and arrangement of cells and tissues under a microscope.

The report may provide information about:

• Benign or malignant changes
• Invasive breast cancer
• Ductal carcinoma in situ (DCIS)
• Lobular carcinoma in situ (LCIS)
• Invasive ductal carcinoma
• Invasive lobular carcinoma
• Tumor grade
• Necrosis
• Lymphovascular invasion
• Margins in surgical specimens
• Other associated breast tissue changes

Histopathology therefore establishes the basic pathological diagnosis before additional biomarker tests are interpreted.

What is Immunohistochemistry (IHC) Testing in Breast Cancer?

Immunohistochemistry, commonly called IHC, uses specific antibodies to identify proteins present in breast cancer cells.

IHC is particularly important because breast cancer is biologically diverse. Two tumors that look similar under a microscope may respond differently to treatment because their molecular characteristics are different.

IHC may be used to evaluate:

• Estrogen and progesterone receptors
• HER2 protein expression
• Ki-67
• Other markers when clinically indicated

The results help doctors understand the biology of the tumor and select suitable treatment options.

What is Estrogen Receptor (ER) Testing?

Hormone Receptor Test or Estrogen receptor testing determines whether breast cancer cells contain receptors that can respond to the hormone estrogen.

If breast cancer cells express estrogen receptors, the tumor is generally considered ER-positive.

ER testing is important because hormone receptor-positive breast cancers may benefit from endocrine or hormonal therapy.

The pathology report usually describes the percentage of tumor cells showing receptor expression along with the intensity or interpretation according to the laboratory's reporting criteria.

What is Progesterone Receptor (PR) Testing?

Progesterone receptor testing evaluates whether the breast cancer cells express progesterone receptors.

PR results are interpreted together with ER status and other tumor characteristics.

PR testing can help:

• Characterize the tumor
• Support prognosis assessment
• Guide systemic treatment decisions
• Determine whether endocrine therapy may be appropriate

ER and PR are commonly referred to together as hormone receptor testing.

What is HER2 Testing in Breast Cancer?

HER2 testing evaluates human epidermal growth factor receptor 2, a protein that may be present at increased levels in certain breast cancers.

HER2 testing is important because HER2-positive breast cancers can potentially respond to specific HER2-targeted therapies.

The initial assessment is often performed using HER2 IHC testing.

Depending on the IHC result, additional testing such as in-situ hybridization (ISH) may be recommended to clarify HER2 gene amplification.

Therefore, HER2 testing can provide important information for selecting targeted treatment.

What is Ki-67 Testing?

Ki-67 is a marker associated with cell proliferation.

A Ki-67 test estimates the proportion of tumor cells showing Ki-67 expression and can provide information about how actively the cancer cells are multiplying.

Ki-67 may be considered along with:

• Tumor grade
• ER and PR status
• HER2 status
• Histological type
• Other clinical and pathological findings

Because Ki-67 assessment can vary between laboratories and interpretation methods, it should not generally be considered in isolation when making treatment decisions.

What is Molecular Testing of Breast Tumor Tissue?

Some breast cancer cases may require additional molecular or genomic testing.

These tests examine genes or molecular characteristics associated with the tumor.

Depending on the cancer subtype and clinical situation, molecular testing may help doctors:

• Estimate recurrence risk
• Understand tumor biology
• Identify specific molecular alterations
• Determine whether a targeted treatment may be appropriate
• Support decisions about systemic therapy

Not every patient requires molecular testing. The appropriate test depends on the pathology report, stage, tumor subtype, and treatment question being addressed.

What Tests are Done on Breast Tissue to Identify the Type of Cancer?

Breast cancer includes several pathological subtypes. Laboratory examination helps determine the specific diagnosis.

Common findings may include:

Invasive Ductal Carcinoma

Cancer begins in the milk ducts and extends into surrounding breast tissue. It is one of the most frequently diagnosed invasive breast cancer types.

Invasive Lobular Carcinoma

This cancer develops from the milk-producing lobules and may have a different growth pattern from ductal carcinoma.

Ductal Carcinoma in Situ

DCIS is a non-invasive breast condition in which abnormal cells remain within the milk ducts.

Lobular Carcinoma in Situ

LCIS involves abnormal cells within the breast lobules and has different clinical implications from invasive breast cancer.

The final diagnosis depends on microscopic examination of the actual tissue specimen.

What is Tumor Grade Testing?

Tumor grade describes how different the cancer cells appear from normal breast cells and provides an indication of their biological characteristics.

Pathologists assess features such as:

• Tubule formation
• Nuclear characteristics
• Mitotic activity

These findings contribute to the histological grade of the tumor.

Tumor grade is different from cancer stage. Grade describes the characteristics of the cancer cells, whereas stage considers the extent of disease in the body.

What Tests Are Done on Breast Tissue After Surgery?

A larger breast specimen obtained during surgery allows the pathology team to examine the tumor and surrounding tissue in greater detail.

A surgical pathology examination may evaluate:

• Tumor size
• Histological type
• Tumor grade
• Tumor margins
• Lymphovascular invasion
• Skin or nipple involvement when applicable
• Chest wall involvement when applicable
• Lymph nodes
• ER status
• PR status
• HER2 status
• Other relevant biomarkers

This information can help the oncology team determine whether additional treatment is required after surgery.

What is Margin Testing in Breast Cancer?

When breast cancer is removed surgically, the pathologist examines the edges, or margins, of the removed tissue.

Margin assessment helps determine whether cancer cells extend to the edge of the surgical specimen.

The report may describe the relationship between the tumor and the surgical margins.

This information is particularly important when doctors are evaluating whether the cancer has been adequately removed and whether further local treatment may be necessary.

What Laboratory Tests Are Done on Lymph Node Tissue?

If lymph nodes are removed or sampled during breast cancer treatment, the tissue can undergo pathological examination.

Lymph node pathology can determine whether cancer cells have spread from the breast into the lymphatic system.

The report may include:

• Number of lymph nodes examined
• Number containing cancer
• Size of metastatic deposits
• Presence of extranodal extension when applicable

Lymph node findings contribute to the pathological staging of breast cancer and may influence subsequent treatment.

What is Sentinel Lymph Node Pathology?

During a sentinel lymph node procedure, one or more lymph nodes that are most likely to receive drainage from the breast tumor are removed and examined.

The laboratory examines these nodes for cancer cells.

Sentinel node evaluation can help determine whether cancer has begun spreading through the lymphatic system while potentially avoiding unnecessary removal of a larger number of lymph nodes in selected patients.

Can Additional Tests Be Performed on Breast Biopsy Tissue?

Yes. If the initial pathology findings raise additional questions, the laboratory may perform further investigations.

Depending on the case, these may include:

• Additional IHC markers
• Special stains
• ISH testing
• Molecular tests
• Genetic or genomic assays
• Tests to distinguish between different tumor types

The selection of additional testing should be based on the patient's pathology and the specific clinical question.

How Do Breast Tissue Laboratory Tests Help in Treatment Planning?

The pathology and biomarker results are combined with other information such as:

• Patient's clinical findings
• Mammography
• Ultrasound
• Breast MRI when indicated
• Tumor size
• Lymph node findings
• Cancer stage
• Menopausal status and other relevant factors
• Overall health

This integrated assessment helps the multidisciplinary cancer team decide on an appropriate treatment strategy.

Depending on the individual case, treatment may involve:

• Breast-conserving surgery
• Mastectomy
• Lymph node surgery
• Chemotherapy
• Hormonal therapy
• HER2-targeted therapy
• Immunotherapy
• Radiation therapy
• Other systemic treatments

What is the Difference Between Breast Tissue Tests and Breast Imaging?

Breast imaging and laboratory pathology answer different questions.

Breast imaging helps doctors identify and locate abnormalities. It may include:

• Mammography
• Breast ultrasound
• MRI

Breast tissue testing examines cells and tissue obtained through biopsy or surgery.

It can determine:

• Whether cancer is present
• What type of cancer it is
• Tumor grade
• Biomarker status
• Other pathological characteristics

In many breast cancer cases, imaging and pathology complement each other rather than replacing one another.

Why is Accurate Breast Tissue Testing Important?

A breast cancer diagnosis should be based on reliable pathological assessment because treatment decisions can depend heavily on the tumor's biological characteristics.

Accurate tissue testing helps reduce the possibility of:

• Misclassification of a tumor
• Incorrect determination of tumor subtype
• Inappropriate treatment selection
• Missing important biomarkers
• Unnecessary treatment

For this reason, biopsy handling, tissue processing, pathological examination, and biomarker testing are all important components of breast cancer care.

When Should a Doctor Recommend Breast Tissue Testing?

Breast tissue testing may be recommended when there is a suspicious finding such as:

• A new breast lump
• An abnormal mammogram
• A suspicious ultrasound finding
• An MRI-detected lesion
• Nipple changes or abnormal discharge
• Skin changes associated with a breast abnormality
• Enlarged or suspicious lymph nodes
• A lesion that requires pathological confirmation

Not every breast lump requires a biopsy. The decision depends on clinical examination and imaging findings.

Why Choose Tender Palm Super-Speciality Hospital for Breast Tissue Testing in Lucknow, India?

 

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back